Appendix 3
附錄
3
3
審議規劃發展公立醫院及相關服務的整體優先次序，
並作出建議，確保最有效地運用所獲資源；
4
審議及檢討規劃發展公立醫院及相關服務的任何其他
事宜，並作出建議；
5
定期審議醫療服務發展範疇的相關風險、風險管理及
風險緩減事宜；及
6
就以下事宜行使醫院管理局大會授予的權力：
(a)
批核撒瑪利亞基金管理委員會建議的基金涵蓋
範圍；
(b)
批核專科服務及重建項目的臨床服務計劃，惟
涉及財政撥款的決定者除外。
2013-14
ϋ
ܓ
ʈЪ฿
ر
在
2013-14
年度，醫療服務發展委員會共召開五次會議，討
論臨床服務的規劃、發展及管理事項。在臨床服務規劃及
發展方面，委員會考慮及審議住院、日間及外展服務的預測
需求、醫生、護士、專職醫療及藥劑專業人員的人手需求和
策略、九龍中醫院聯網臨床服務計劃的制訂、冠心病服務策
略、中風科服務發展計劃、中西醫結合發展策略框架、在伊
利沙伯醫院（伊院）重置油麻地專科診所，以及翻修伊院癌
症研究實驗室。
委員會審議不同醫療管理事項，並提供意見，包括撒瑪利亞
基金在
2013-14
年度起納入新藥及適應症、醫管局藥物名冊
管理、醫管局專科門診診所及非緊急手術輪候時間管理、未
來五年急症室服務方向、臨床績效表現監察、主要表現指標
年度檢討、醫管局醫護人員模擬訓練、冬季流感高峰期應對
準備、香港遺體器官指定捐贈及對非本地居民的移植政策、
改革香港眼科醫院私家診所建議，以及
2014
年病人服務及
治療風險與風險防範計劃建議。
委員會亦收閱各項臨床服務計劃的進展報告，包括三方合作
模式中醫藥教研中心的合約管理、醫管局病人服務滿意度調
查，以及多個公私營協作服務計劃的進展。
為體現良好機構管治，委員會進行了自我評核，根據其職權
範圍檢討過去一年的工作。
3.
Consider and make recommendations on the overall priorities for the
planning and development of the public hospitals and related services in
order to ensure an optimal utilisation of available resources;
4.
Consider, review and make recommendations on any other matters
related to the planning and development of the public hospitals and
related services;
5.
Consider periodically matters relating to risk, risk management and risk
mitigation relevant to medical services development; and
6.
Exercise powers delegated by the Board on the following matters:
(a)
Approve the scope of coverage of the Samaritan Fund as recommended
by the Management Committee of the Samaritan Fund,
(b)
Approve clinical service plans on specialty services and
redevelopment projects, except those involving decisions on
financial provisions.
Focus ofWork in 2013-14
In 2013-14, the Committee met five times to discuss issues relating to the
planning, development and management of clinical services. On clinical
services planning and development, the Committee considered and
deliberated on the service demand projection for inpatient, ambulatory and
outreach services; manpower requirement and strategies for doctors, nurses,
allied health and pharmacy professionals; development of clinical services plan
for the Kowloon Central Cluster; strategic service framework for coronary heart
disease; stroke service development plan; framework for the development of
Integrated Chinese-Western Medicine; reprovisioning of Yaumatei Specialist
Clinic at Queen Elizabeth Hospital (QEH); and the renovation of the Cancer
Research Laboratory at QEH.
The Committee considered and gave advice on clinical management issues
relating to the introduction of new drugs and indications to be covered by
the Samaritan Fund from 2013-14; management of the HA Drug Formulary;
waiting time management for specialist outpatient clinics and elective surgery
in HA; direction of accident and emergency services in the coming five years;
clinical performance monitoring; annual review on key performance indicators;
simulation training for healthcare professionals in HA; winter surge preparation;
directed donation of deceased organs in Hong Kong and transplant policy for
non-local residents; proposal on reforming the private clinic of Hong Kong Eye
Hospital; and the patient service and care risks and the proposed risk reduction
plans for 2014.
The Committee also received progress reports of various clinical programmes,
including the contract management of Chinese Medicine Clinic for Research
and Training under the tripartite arrangement; HA Patient Satisfaction Survey;
and progress of various public-private partnership service programmes.
As a good corporate governance practice, the Committee conducted a self-
assessment exercise in reviewing its activities in the past year according to its
Terms of Reference.
166
Hospital Authority Annual Report 2013-2014
